Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation (vol 109, pg 1149, 2024)

Zachary D. Epstein-Peterson; Esther Drill; Umut Aypar; Connie Lee Batlevi; Philip Caron; Ahmet Dogan; Pamela Drullinsky; John Gerecitano; Paul A. Hamlin; Caleb Ho; Allison Jacob; Ashlee Joseph; Leana Laraque; Matthew J. Matasar; Alison J. Moskowitz; Craig H. Moskowitz; Chelsea Mullins; Colette Owens; Gilles Salles; Heiko Schoder; David J. Straus; Anas Younes; Andrew D. Zelenetz; Anita Kumar

doi:10.3324/haematol.2024.285845

Back

Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation (vol 109, pg 1149, 2024)

Journal article

Peer reviewed

Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation (vol 109, pg 1149, 2024)

Zachary D. Epstein-Peterson, Esther Drill, Umut Aypar, Connie Lee Batlevi, Philip Caron, Ahmet Dogan, Pamela Drullinsky, John Gerecitano, Paul A. Hamlin, Caleb Ho, …

Haematologica (Roma), Vol.109(8)

2024-08-01

DOI: https://doi.org/10.3324/haematol.2024.285845

PMID: 39087412

Appears in Miller School of Medicine - Latest Publications

Abstract

Hematology

Life Sciences & Biomedicine

Science & Technology

Files and links (1)

url

https://doi.org/10.3324/haematol.2024.285845View

Published (Version of record) Open

Metrics

1 Record Views

Details

Title: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation (vol 109, pg 1149, 2024)
Creators: Zachary D. Epstein-Peterson - Memorial Sloan Kettering Cancer Center
Esther Drill - Memorial Sloan Kettering Cancer Center
Umut Aypar - Memorial Sloan Kettering Cancer Center
Connie Lee Batlevi - Memorial Sloan Kettering Cancer Center
Philip Caron - Memorial Sloan Kettering Cancer Center
Ahmet Dogan - Memorial Sloan Kettering Cancer Center
Pamela Drullinsky - Memorial Sloan Kettering Cancer Center
John Gerecitano - Memorial Sloan Kettering Cancer Center
Paul A. Hamlin - Memorial Sloan Kettering Cancer Center
Caleb Ho - Memorial Sloan Kettering Cancer Center
Allison Jacob - Adaptive Biotechnologies
Ashlee Joseph - Memorial Sloan Kettering Cancer Center
Leana Laraque - Memorial Sloan Kettering Cancer Center
Matthew J. Matasar - Memorial Sloan Kettering Cancer Center
Alison J. Moskowitz - Memorial Sloan Kettering Cancer Center
Craig H. Moskowitz - Memorial Sloan Kettering Cancer Center
Chelsea Mullins - Adaptive Biotechnologies
Colette Owens - Memorial Sloan Kettering Cancer Center
Gilles Salles - Memorial Sloan Kettering Cancer Center
Heiko Schoder - Memorial Sloan Kettering Cancer Center
David J. Straus - Memorial Sloan Kettering Cancer Center
Anas Younes - Memorial Sloan Kettering Cancer Center
Andrew D. Zelenetz - Memorial Sloan Kettering Cancer Center
Anita Kumar - Memorial Sloan Kettering Cancer Center
Publication Details: Haematologica (Roma), Vol.109(8)
Publisher: Ferrata Storti Foundation
Number of pages: 4
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
PMID: 39087412
Record Identifier: 991032860879002976